Lars Fruergaard Jørgensen

New Capabilities

Defending market position against Lilly's oral entry

For two years, the most effective weight-loss drugs on the market required a weekly injection. That barrier is now falling. Eli Lilly began shipping Foundayo — the first oral GLP-1 weight-loss pill that can be taken any time of day without food or water restrictions — on April 6, 2026, just five days after the Food and Drug Administration (FDA) approved it in a record 50-day review. Priced at $149 per month for self-pay patients and as low as $25 with commercial insurance, Foundayo undercuts the list price of injectable alternatives by roughly 85%.

Updated 4 hours ago